BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 31404090)

  • 1. Secretome profiling of PC3/nKR cells, a novel highly migrating prostate cancer subline derived from PC3 cells.
    Jeon JM; Kwon OK; Na AY; Sung EJ; Cho IJ; Kim M; Yea SS; Chun SY; Lee JH; Ha YS; Kwon TG; Lee S
    PLoS One; 2019; 14(8):e0220807. PubMed ID: 31404090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correction: Secretome profiling of PC3/nKR cells, a novel highly migrating prostate cancer subline derived from PC3 cells.
    Jeon JM; Kwon OK; Na AY; Sung EJ; Cho IJ; Kim M; Yea SS; Chun SY; Lee JN; Ha YS; Kwon TG; Lee S
    PLoS One; 2019; 14(9):e0222693. PubMed ID: 31518368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosomes secreted by prostate cancer cells under hypoxia promote matrix metalloproteinases activity at pre-metastatic niches.
    Deep G; Jain A; Kumar A; Agarwal C; Kim S; Leevy WM; Agarwal R
    Mol Carcinog; 2020 Mar; 59(3):323-332. PubMed ID: 31943365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of prostate cancer cell migration toward bone marrow stromal cell-conditioned medium by Wnt5a signaling.
    Jin F; Qu X; Fan Q; Wang L; Tang T; Hao Y; Dai K
    Mol Med Rep; 2013 Nov; 8(5):1486-92. PubMed ID: 24064566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HO-1 Interactors Involved in the Colonization of the Bone Niche: Role of ANXA2 in Prostate Cancer Progression.
    Anselmino N; Bizzotto J; Sanchis P; Lage-Vickers S; Ortiz E; Valacco P; Paez A; Labanca E; Meiss R; Navone N; Cotignola J; Vazquez E; Gueron G
    Biomolecules; 2020 Mar; 10(3):. PubMed ID: 32197509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling.
    Wang W; Wang L; Mizokami A; Shi J; Zou C; Dai J; Keller ET; Lu Y; Zhang J
    Chin J Cancer; 2017 Mar; 36(1):35. PubMed ID: 28356132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the anticancer and anti-metastasis effects of novel synthetic sodium channel blockers in prostate cancer cells in vitro and in vivo.
    Wang J; Lu Z; Wu C; Li Y; Kong Y; Zhou R; Shi K; Guo J; Li N; Liu J; Song W; Wang H; Zhu M; Xu H
    Prostate; 2019 Jan; 79(1):62-72. PubMed ID: 30242862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dimethylarginine dimethylaminohydrolase-1 (DDAH1) is frequently upregulated in prostate cancer, and its overexpression conveys tumor growth and angiogenesis by metabolizing asymmetric dimethylarginine (ADMA).
    Reddy KRK; Dasari C; Duscharla D; Supriya B; Ram NS; Surekha MV; Kumar JM; Ummanni R
    Angiogenesis; 2018 Feb; 21(1):79-94. PubMed ID: 29150732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Role of NKR-P1A (CD161) and Lectin-like Transcript 1 in Natural Cytotoxicity against Human Articular Chondrocytes.
    Białoszewska A; Olkowska-Truchanowicz J; Bocian K; Osiecka-Iwan A; Czop A; Kieda C; Malejczyk J
    J Immunol; 2018 Jan; 200(2):715-724. PubMed ID: 29212911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization and comparison of the lytic function of NKR-P1+ and NKR-P1-rat natural killer cell clones established from NKR-P1bright/TCR alpha beta-cell lines.
    Brissette-Storkus C; Appasamy PM; Hayes LA; Kaufman CL; Ildstad ST; Chambers WH
    Nat Immun; 1995; 14(2):98-113. PubMed ID: 8601077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Yes-mediated phosphorylation of focal adhesion kinase at tyrosine 861 increases metastatic potential of prostate cancer cells.
    Chatterji T; Varkaris AS; Parikh NU; Song JH; Cheng CJ; Schweppe RE; Alexander S; Davis JW; Troncoso P; Friedl P; Kuang J; Lin SH; Gallick GE
    Oncotarget; 2015 Apr; 6(12):10175-94. PubMed ID: 25868388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ischemia-responsive protein 94 (Irp94) activates dendritic cells through NK cell receptor protein-2/NK group 2 member D (NKR-P2/NKG2D) leading to their maturation.
    Srivastava RM; Varalakshmi C; Khar A
    J Immunol; 2008 Jan; 180(2):1117-30. PubMed ID: 18178852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of 15-lipoxygenase-1 in PC-3 human prostate cancer cells increases tumorigenesis.
    Kelavkar UP; Nixon JB; Cohen C; Dillehay D; Eling TE; Badr KF
    Carcinogenesis; 2001 Nov; 22(11):1765-73. PubMed ID: 11698337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IFN-β activates cytotoxic function of human natural killer cells toward IL-27 and poly(I:C) stimulated PC3 and DU145 cells.
    Kourko O; Hawke LG; Ormiston ML; Gee K
    Cell Immunol; 2023 May; 387():104718. PubMed ID: 37068442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genistein treatment duration effects biomarkers of cell motility in human prostate.
    Zhang H; Gordon R; Li W; Yang X; Pattanayak A; Fowler G; Zhang L; Catalona WJ; Ding Y; Xu L; Huang X; Jovanovic B; Kelly DL; Jiang H; Bergan R
    PLoS One; 2019; 14(3):e0214078. PubMed ID: 30917169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotype and Function of Activated Natural Killer Cells From Patients With Prostate Cancer: Patient-Dependent Responses to Priming and IL-2 Activation.
    Hood SP; Foulds GA; Imrie H; Reeder S; McArdle SEB; Khan M; Pockley AG
    Front Immunol; 2018; 9():3169. PubMed ID: 30761160
    [No Abstract]   [Full Text] [Related]  

  • 17. Interleukin-4 induces a CD44
    Erb HHH; Guggenberger F; Santer FR; Culig Z
    J Cell Biochem; 2018 May; 119(5):4103-4112. PubMed ID: 29236307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomics approach to identify novel metastatic bone markers from the secretome of PC-3 prostate cancer cells.
    Sung E; Kwon OK; Lee JM; Lee S
    Electrophoresis; 2017 Oct; 38(20):2638-2645. PubMed ID: 28627741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon gamma production by natural killer (NK) cells and NK1.1+ T cells upon NKR-P1 cross-linking.
    Arase H; Arase N; Saito T
    J Exp Med; 1996 May; 183(5):2391-6. PubMed ID: 8642351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 15-lipoxygenase-1 expression upregulates and activates insulin-like growth factor-1 receptor in prostate cancer cells.
    Kelavkar UP; Cohen C
    Neoplasia; 2004; 6(1):41-52. PubMed ID: 15068670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.